Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak. Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point. However, this trade only works if you are comfortable holding the stock through a turnaround, particularly as both of the company's core growth drivers—WATCHMAN and electrophysiology—face sudden operational headwinds.
Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.
Collect roughly $135 in premium per contract (each contract covers 100 shares).
That works out to about 4.4% annualized on the $3,000 of cash you set aside to secure the trade.
Park that collateral in Treasury bills or a Treasury money-market fund yielding roughly 3.9%, boosting your total cash-secured return to about 8.3%.

#secured #works #trading #scientific